6-34022847-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_000841.4(GRM4):c.2713G>A(p.Val905Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000477 in 1,613,932 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000841.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRM4 | NM_000841.4 | c.2713G>A | p.Val905Ile | missense_variant | 11/11 | ENST00000538487.7 | NP_000832.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRM4 | ENST00000538487.7 | c.2713G>A | p.Val905Ile | missense_variant | 11/11 | 2 | NM_000841.4 | ENSP00000440556 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152222Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000400 AC: 10AN: 249822Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135166
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461710Hom.: 0 Cov.: 30 AF XY: 0.0000261 AC XY: 19AN XY: 727164
GnomAD4 genome AF: 0.000217 AC: 33AN: 152222Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2024 | The c.2713G>A (p.V905I) alteration is located in exon 10 (coding exon 10) of the GRM4 gene. This alteration results from a G to A substitution at nucleotide position 2713, causing the valine (V) at amino acid position 905 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at